KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 152 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $1,004,000 | +186.0% | 295,513 | +216.5% | 0.00% | – |
| Q2 2018 | $351,000 | -11.4% | 93,369 | -3.5% | 0.00% | – |
| Q1 2018 | $396,000 | +5.3% | 96,759 | +19.6% | 0.00% | – |
| Q4 2017 | $376,000 | -39.5% | 80,925 | -7.4% | 0.00% | – |
| Q3 2017 | $622,000 | +0.8% | 87,432 | +2.5% | 0.00% | – |
| Q2 2017 | $617,000 | +67.7% | 85,307 | +42.6% | 0.00% | – |
| Q1 2017 | $368,000 | -39.0% | 59,818 | -41.9% | 0.00% | – |
| Q4 2016 | $603,000 | +9.4% | 103,041 | -0.7% | 0.00% | – |
| Q3 2016 | $551,000 | -18.9% | 103,750 | +1.2% | 0.00% | – |
| Q2 2016 | $679,000 | -11.7% | 102,552 | -37.7% | 0.00% | -100.0% |
| Q1 2016 | $769,000 | +51.4% | 164,593 | +64.0% | 0.00% | – |
| Q4 2015 | $508,000 | -17.7% | 100,370 | -42.7% | 0.00% | – |
| Q3 2015 | $617,000 | -11.2% | 175,309 | +152.1% | 0.00% | – |
| Q2 2015 | $695,000 | +110.0% | 69,544 | +167.8% | 0.00% | – |
| Q1 2015 | $331,000 | +4.4% | 25,972 | +16.0% | 0.00% | – |
| Q4 2014 | $317,000 | -0.6% | 22,386 | -3.4% | 0.00% | – |
| Q3 2014 | $319,000 | +67.9% | 23,185 | +87.4% | 0.00% | – |
| Q2 2014 | $190,000 | -60.2% | 12,370 | -55.9% | 0.00% | – |
| Q1 2014 | $477,000 | +1.1% | 28,057 | -22.9% | 0.00% | – |
| Q4 2013 | $472,000 | +604.5% | 36,406 | +450.4% | 0.00% | – |
| Q3 2013 | $67,000 | -20.2% | 6,615 | -40.7% | 0.00% | – |
| Q2 2013 | $84,000 | – | 11,163 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $3 | 0.00% |